- Home
- CSTL vs EBF Comparison
CSTL vs EBF Comparison
Compare CSTL & EBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- EBF
- Stock Information
- Founded
- CSTL 2007
- EBF 1909
- Country
- CSTL United States
- EBF United States
- Employees
- CSTL N/A
- EBF N/A
- Industry
- CSTL Medical Specialities
- EBF Office Equipment/Supplies/Services
- Sector
- CSTL Health Care
- EBF Consumer Discretionary
- Exchange
- CSTL Nasdaq
- EBF Nasdaq
- Market Cap
- CSTL 456.2M
- EBF 488.0M
- IPO Year
- CSTL 2019
- EBF N/A
- Fundamental
- Price
- CSTL $18.52
- EBF $18.29
- Analyst Decision
- CSTL Strong Buy
- EBF
- Analyst Count
- CSTL 6
- EBF 0
- Target Price
- CSTL $37.67
- EBF N/A
- AVG Volume (30 Days)
- CSTL 419.5K
- EBF 133.2K
- Earning Date
- CSTL 08-04-2025
- EBF 06-27-2025
- Dividend Yield
- CSTL N/A
- EBF 5.48%
- EPS Growth
- CSTL N/A
- EBF N/A
- EPS
- CSTL N/A
- EBF 1.54
- Revenue
- CSTL $347,083,000.00
- EBF $394,618,000.00
- Revenue This Year
- CSTL N/A
- EBF $1.15
- Revenue Next Year
- CSTL $1.36
- EBF N/A
- P/E Ratio
- CSTL N/A
- EBF $11.84
- Revenue Growth
- CSTL 38.43
- EBF N/A
- 52 Week Low
- CSTL $15.45
- EBF $17.15
- 52 Week High
- CSTL $35.84
- EBF $25.75
- Technical
- Relative Strength Index (RSI)
- CSTL 56.09
- EBF 41.24
- Support Level
- CSTL $17.89
- EBF $18.40
- Resistance Level
- CSTL $19.38
- EBF $18.75
- Average True Range (ATR)
- CSTL 0.82
- EBF 0.30
- MACD
- CSTL 0.26
- EBF -0.02
- Stochastic Oscillator
- CSTL 77.46
- EBF 5.56
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialities, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360º Custom LabelsSM, ColorWorx, Enfusion, among others.